Newly synthesized chitosan nanoparticles loaded with caffeine/moringa leaf extracts Halt Her2, BRCA1, and BRCA2 expressions.

Hanaa Mohammed, Mustafa M Karhib, Karrar Sabah Jaafar Al-Fahad, Atef Mohamed Atef, Areej Eskandrani, Amira Abd-Elfattah Darwish, Ahmed Abdallah Sary, Bassma H Elwakil, Basant A Bakr, Ahmed M Eldrieny
Author Information
  1. Hanaa Mohammed: Human Anatomy and Embryology Department, Faculty of Medicine, Sohag University, Sohag, Egypt.
  2. Mustafa M Karhib: Department of Medical Laboratory Techniques, College of Health and Medical Technologies, Al-Mustaqbal University, Hillah, Babylon, 51001, Iraq.
  3. Karrar Sabah Jaafar Al-Fahad: Babylon Education Directorate, Ministry of Education, Hillah, Iraq.
  4. Atef Mohamed Atef: Faculty of Medical Applied Science, Irbid National University, Irbid, Jordan.
  5. Areej Eskandrani: College of Science, Taibah University, 30002, Madinah, Kingdom of Saudi Arabia.
  6. Amira Abd-Elfattah Darwish: Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, 21526, Egypt.
  7. Ahmed Abdallah Sary: Faculty of Physical Therapy, Pharos University in Alexandria, Alexandria, 21526, Egypt.
  8. Bassma H Elwakil: Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, 21526, Egypt. Bassma.hassan@pua.edu.eg.
  9. Basant A Bakr: Faculty of Science, Alexandria University, Alexandria, 21321, Egypt.
  10. Ahmed M Eldrieny: Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, 21526, Egypt.

Abstract

Breast cancer is among the highest morbidity and mortality rates in women around the world. In the present investigation we aimed to synthesis novel nanosystem combining two naturally important anticancer agents with different mechanism of action namely Moringa oleifera and caffeine. Firstly, chemical analysis of Moringa oleifera extract and caffeine was done by gas chromatography-mass spectroscopy (GC-MS) in order to assess the main chemical compounds present and correlate between them and the possible anticancer effect. The novel nanosystem was characterized through dynamic light scattering techniques which revealed the stability and homogeneity of the prepared M. oleifera leaves extract/Caffeine loaded chitosan nanoparticles, while FTIR and transmission electron microscope (TEM) proved the shape and the successful incorporation of M. oleifera leaves extract/Caffeine onto the nanochitosan carrier. Our initial step was to assess the anticancer effect in vitro in cancer cell line MCF-7 which proved the significant enhanced effect of M. oleifera leaves extract/Caffeine nanosystem compared to M. oleifera leaves extract or caffeine loaded nanoparticles. Further studies were conducted in vivo namely tumor biomarkers, tumor volume, bioluminescence imaging, molecular and histopathological investigations. The present study proved the potent anticancer effect of the synthesized M. oleifera leaves extract/Caffeine loaded chitosan nanoparticles. Mo/Caf/CsNPs exhibited a large number of apoptotic cells within the tumor mass while the adipose tissue regeneration was higher compared to the positive control. The prepared nanoparticles downregulated the expression of Her2, BRCA1 and BRCA2 while mTOR expression was upregulated. The aforementioned data demonstrated the successful synergistic impact of Moringa and caffeine in decreasing the carcinoma grade.

Keywords

References

  1. Asian Pac J Cancer Prev. 2023 Mar 01;24(3):833-840 [PMID: 36974535]
  2. Clin Cancer Res. 2015 Apr 15;21(8):1877-87 [PMID: 25691730]
  3. Bioconjug Chem. 2016 Oct 19;27(10):2225-2238 [PMID: 27547843]
  4. Biomolecules. 2020 Sep 02;10(9): [PMID: 32887473]
  5. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):895-901 [PMID: 18398030]
  6. Drug Chem Toxicol. 2023 Nov;46(6):1070-1082 [PMID: 36196508]
  7. Front Biosci. 2008 May 01;13:3273-87 [PMID: 18508432]
  8. Mar Drugs. 2014 Jan 07;12(1):128-52 [PMID: 24402174]
  9. J Biol Chem. 2015 Jul 17;290(29):17724-17732 [PMID: 26048987]
  10. JBRA Assist Reprod. 2018 Nov 01;22(4):289-300 [PMID: 30106540]
  11. Saudi J Biol Sci. 2022 Mar;29(3):1832-1841 [PMID: 35280562]
  12. Nat Rev Cancer. 2009 Dec;9(12):874-85 [PMID: 19935676]
  13. PLoS One. 2015 Aug 19;10(8):e0135814 [PMID: 26288313]
  14. Life Sci. 2016 Sep 1;160:47-56 [PMID: 27449398]
  15. Tumour Biol. 2018 May;40(5):1010428318776169 [PMID: 29775157]
  16. Int J Pharm. 2022 Nov 25;628:122184 [PMID: 36252641]
  17. BMC Complement Altern Med. 2013 Sep 16;13:226 [PMID: 24041017]
  18. Ann Surg Oncol. 2021 Nov;28(12):7356-7365 [PMID: 33966140]
  19. Drug Des Devel Ther. 2016 Nov 04;10:3611-3632 [PMID: 27853354]
  20. Pharmacol Rev. 2001 Mar;53(1):25-71 [PMID: 11171938]
  21. Drug Deliv Transl Res. 2024 Feb;14(2):433-454 [PMID: 37644299]
  22. Sci Data. 2023 May 27;10(1):334 [PMID: 37244901]
  23. CA Cancer J Clin. 2021 May;71(3):209-249 [PMID: 33538338]
  24. Annu Rev Physiol. 2008;70:431-57 [PMID: 17850209]
  25. J Mammary Gland Biol Neoplasia. 2001 Apr;6(2):183-92 [PMID: 11501578]
  26. J Clin Nurs. 2020 Mar;29(5-6):758-769 [PMID: 31769562]
  27. Antibiotics (Basel). 2022 Jul 07;11(7): [PMID: 35884170]
  28. Science. 1989 May 12;244(4905):707-12 [PMID: 2470152]
  29. J Pharm Sci. 2015 Jan;104(1):266-75 [PMID: 25418056]
  30. Int J Hyperthermia. 2010;26(7):681-5 [PMID: 20653417]
  31. Medicines (Basel). 2019 Mar 14;6(1): [PMID: 30875823]
  32. Int J Mol Med. 2018 Dec;42(6):3542-3550 [PMID: 30221688]
  33. Biomater Res. 2021 May 8;25(1):17 [PMID: 33964968]
  34. Asian Pac J Cancer Prev. 2014;15(20):8571-6 [PMID: 25374169]
  35. Molecules. 2022 Jul 11;27(14): [PMID: 35889305]
  36. Genes Nutr. 2015 Nov;10(6):51 [PMID: 26577824]
  37. Pharmaceuticals (Basel). 2020 Dec 15;13(12): [PMID: 33333817]
  38. PLoS One. 2015 Dec 14;10(12):e0144954 [PMID: 26660901]
  39. J Ethnopharmacol. 2020 Mar 01;249:112401 [PMID: 31739103]
  40. Adv Enzyme Regul. 2001;41:189-207 [PMID: 11384745]
  41. Cancer Causes Control. 2013 May;24(5):929-40 [PMID: 23412805]
  42. Mol Biol Rep. 2022 Nov;49(11):10217-10228 [PMID: 36063350]
  43. Life Sci Alliance. 2019 Nov 14;2(6): [PMID: 31727800]
  44. Biochem Pharmacol. 2013 Feb 15;85(4):449-65 [PMID: 23103568]
  45. Phytochemistry. 2019 Apr;160:1-10 [PMID: 30641334]
  46. Clin Chim Acta. 2010 Dec 14;411(23-24):1869-74 [PMID: 20816948]
  47. Anesth Pain Med. 2016 Mar 26;6(3):e33193 [PMID: 27642573]
  48. Breast Cancer Res Treat. 2012 Feb;132(1):61-73 [PMID: 21541704]
  49. Molecules. 2020 Nov 26;25(23): [PMID: 33256012]
  50. Life Sci. 2020 May 1;248:117454 [PMID: 32088211]
  51. Breast. 2012 Aug;21(4):604-7 [PMID: 22560618]
  52. Eur J Cancer. 2004 Jul;40(11):1768-75 [PMID: 15251168]
  53. Int J Mol Sci. 2019 Apr 09;20(7): [PMID: 30970626]
  54. J Surg Sci. 2014 Dec;2(1):4-9 [PMID: 25679012]
  55. Adv Drug Deliv Rev. 2014 Feb;66:2-25 [PMID: 24270007]
  56. Pharmaceutics. 2022 Nov 08;14(11): [PMID: 36365222]
  57. Anticancer Res. 2008 May-Jun;28(3A):1681-5 [PMID: 18630526]
  58. J Clin Oncol. 2008 Jul 1;26(19):3153-8 [PMID: 18490649]

MeSH Term

Chitosan
Humans
Caffeine
Nanoparticles
Plant Leaves
Female
Plant Extracts
MCF-7 Cells
BRCA2 Protein
Receptor, ErbB-2
Breast Neoplasms
BRCA1 Protein
Animals
Moringa oleifera
Mice
Gene Expression Regulation, Neoplastic

Chemicals

Chitosan
Caffeine
Plant Extracts
BRCA2 Protein
Receptor, ErbB-2
BRCA1 Protein
ERBB2 protein, human
BRCA1 protein, human
BRCA2 protein, human

Word Cloud

Created with Highcharts 10.0.0oleiferaanticancerMleavesnanoparticlescaffeineeffectextract/CaffeineloadedcancerpresentnanosystemMoringachitosanprovedtumorHer2BRCA1BRCA2BreastnovelagentsnamelychemicalextractassesspreparedsuccessfulcarrierMCF-7comparedsynthesizedexpressionmTORamonghighestmorbiditymortalityrateswomenaroundworldinvestigationaimedsynthesiscombiningtwonaturallyimportantdifferentmechanismactionFirstlyanalysisdonegaschromatography-massspectroscopyGC-MSordermaincompoundscorrelatepossiblecharacterizeddynamiclightscatteringtechniquesrevealedstabilityhomogeneityFTIRtransmissionelectronmicroscopeTEMshapeincorporationontonanochitosaninitialstepvitrocelllinesignificantenhancedstudiesconductedvivobiomarkersvolumebioluminescenceimagingmolecularhistopathologicalinvestigationsstudypotentMo/Caf/CsNPsexhibitedlargenumberapoptoticcellswithinmassadiposetissueregenerationhigherpositivecontroldownregulatedupregulatedaforementioneddatademonstratedsynergisticimpactdecreasingcarcinomagradeNewlycaffeine/moringaleafextractsHaltexpressionsChitosanNanoNatural

Similar Articles

Cited By (1)